Weight loss on Farxiga is gradual, not dramatic. Most people lose about 6 pounds over the first 24 weeks, with the fastest changes happening in the first three months. This is a slower pace than newer weight loss medications, but the loss is steady and largely comes from actual body fat rather than just water weight.
How Farxiga Causes Weight Loss
Farxiga (dapagliflozin) works by blocking the kidneys from reabsorbing glucose back into the bloodstream. Instead, your body flushes roughly 70 to 80 grams of glucose out through urine each day. That translates to a caloric deficit of about 280 to 320 calories daily, similar to skipping a moderate snack or walking briskly for 45 minutes.
This calorie drain happens passively, every day, as long as you take the medication. It’s a modest but consistent deficit, and over weeks and months, it adds up.
What the Timeline Looks Like
In clinical studies, people taking Farxiga lost an average of about 5 pounds (2.4 kg) in the first 12 weeks. By 24 weeks, that number reached roughly 6 pounds (about 3 kg). The rate of loss is steepest in the first few weeks, then gradually slows.
The early phase of weight loss, during the first three months, is partly driven by fluid loss. Farxiga has a mild diuretic effect because the extra glucose in your urine pulls water along with it. After that initial period, the ongoing weight reduction shifts to actual fat loss. One study using body composition scans found that about two-thirds of the total weight lost on Farxiga came from fat, while the remaining third came from lean mass and fluid. The researchers confirmed that calorie loss from glucose in the urine, not fluid loss, was the primary driver of these changes over time.
Weight loss typically plateaus after the first several months. You’re unlikely to see a continuous downward trend beyond that point, but the weight you’ve lost tends to stay off as long as you continue the medication.
Where the Fat Comes From
Farxiga doesn’t just reduce the number on the scale. Body composition research shows it specifically reduces visceral fat (the deep fat around your organs) and subcutaneous fat (the fat under your skin), along with measurable reductions in waist circumference. This matters because visceral fat is closely tied to heart disease and metabolic problems, so losing it carries health benefits beyond what the scale reflects.
Setting Realistic Expectations
If you’re comparing Farxiga to GLP-1 medications like semaglutide, the weight loss is significantly smaller. Those drugs can produce 10 to 15 percent body weight reduction, while Farxiga delivers closer to 2 to 4 percent. The caloric deficit Farxiga creates, around 300 calories a day, simply can’t match the appetite suppression and metabolic effects of drugs designed specifically for weight management.
It’s also worth noting that Farxiga is not FDA-approved for weight loss. Its approved uses are for type 2 diabetes, heart failure, and chronic kidney disease. Weight reduction is a well-documented side effect, and clinicians are aware of it, but it’s not the drug’s primary purpose. If weight loss is your main goal, Farxiga alone is unlikely to produce the results you’re hoping for.
Factors That Affect Your Results
People with higher blood sugar levels tend to lose more weight on Farxiga, because the drug has more glucose available to flush out. If your blood sugar is well controlled or you don’t have diabetes, there’s simply less glucose for the kidneys to excrete, which means a smaller caloric deficit and less weight loss.
Your starting weight, diet, and activity level also play a role. Farxiga creates a fixed caloric deficit of roughly 300 calories per day. If you’re simultaneously eating in a surplus, that deficit gets partially or fully canceled out. Pairing the medication with a balanced diet amplifies results, and one clinical trial exploring Farxiga combined with calorie restriction found the combination more effective than either approach alone for improving metabolic health.
Side Effects Related to Weight Changes
Because Farxiga pulls extra fluid out through urine, especially in the first weeks, dehydration is a real concern. Symptoms include dizziness, feeling faint when you stand up, lightheadedness, and weakness. Your risk is higher if you’re over 65, take blood pressure medications or diuretics, follow a low-salt diet, or have kidney problems.
Ketoacidosis is a less common but serious risk. This happens when your body shifts too aggressively toward burning fat for fuel, producing dangerous levels of acids called ketones. The risk increases if you’re eating very low-carb or ketogenic diets, skipping meals, sick, dehydrated, or drinking heavily. Warning signs include nausea, vomiting, abdominal pain, unusual tiredness, and difficulty breathing. Ketoacidosis can occur even when blood sugar levels appear normal, which makes it easy to miss if you’re only checking glucose numbers.
Staying well hydrated and eating regular meals are the simplest ways to reduce both of these risks while taking Farxiga.